306 related articles for article (PubMed ID: 18234714)
1. Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis.
Liao KP; Batra KL; Chibnik L; Schur PH; Costenbader KH
Ann Rheum Dis; 2008 Nov; 67(11):1557-61. PubMed ID: 18234714
[TBL] [Abstract][Full Text] [Related]
2. Significance of anti-CCP antibodies in modification of 1987 ACR classification criteria in diagnosis of rheumatoid arthritis.
Zhao J; Liu X; Wang Z; Li Z
Clin Rheumatol; 2010 Jan; 29(1):33-8. PubMed ID: 19830383
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
4. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
6. Combining anti-cyclic citrullinated peptide with the American College of Rheumatology 1987 criteria failed to improve early rheumatoid arthritis diagnosis in the community-based very early arthritis cohort.
Le Loët X; Strotz V; Lequerré T; Boumier P; Pouplin S; Mejjad O; Daragon A; Jouen F; Vittecoq O; Fardellone P; Ménard JF
Rheumatology (Oxford); 2011 Oct; 50(10):1901-7. PubMed ID: 21750000
[TBL] [Abstract][Full Text] [Related]
7. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
8. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis].
Cho SY; Kang SY; Lee HJ; Lee WI
Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254
[TBL] [Abstract][Full Text] [Related]
9. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis.
Ateş A; Karaaslan Y; Aksaray S
Clin Rheumatol; 2007 Apr; 26(4):499-504. PubMed ID: 16670828
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of anti-citrullinated protein antibody and its comparison with rheumatoid factor in rheumatoid arthritis.
Khan AH; Jafri L; Hussain MA; Ishaq S
J Coll Physicians Surg Pak; 2012 Nov; 22(11):711-5. PubMed ID: 23146852
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.
Heidari B; Firouzjahi A; Heidari P; Hajian K
Ann Saudi Med; 2009; 29(6):467-70. PubMed ID: 19847085
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
15. [Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis].
Hayashi N; Kumagai S
Rinsho Byori; 2010 May; 58(5):466-79. PubMed ID: 20560456
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
Nell VP; Machold KP; Stamm TA; Eberl G; Heinzl H; Uffmann M; Smolen JS; Steiner G
Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
19. The additional benefit of ultrasonography to 2010 ACR/EULAR classification criteria when diagnosing rheumatoid arthritis in the absence of anti-cyclic citrullinated peptide antibodies.
Ji L; Deng X; Geng Y; Song Z; Zhang Z
Clin Rheumatol; 2017 Feb; 36(2):261-267. PubMed ID: 27848057
[TBL] [Abstract][Full Text] [Related]
20. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
Xie QB; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]